Clinical Trials Logo

Chickenpox clinical trials

View clinical trials related to Chickenpox.

Filter by:

NCT ID: NCT01911065 Completed - Herpes Zoster Clinical Trials

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

Start date: September 2010
Phase: Phase 4
Study type: Interventional

In this study the investigators are trying to identify immune signatures that are associated with effective or poor vaccine responses to naturally-acquired herpes zoster virus and the zoster (shingles) vaccine, Zostavax.

NCT ID: NCT01887496 Completed - Chickenpox Clinical Trials

Varicella-related Hospitalizations in Turkey

VARICOMP
Start date: September 2010
Phase: N/A
Study type: Observational

Epidemiological information on varicella complications in children is essential for the development of appropriate immunization recommendations. Economic analyses of varicella immunization are sensitive to the costs of hospitalized cases, so there is a need to validate varicella-related hospitalization data in a country-specific manner. These data also provide a baseline for comparison with data collected after routine varicella immunization to evaluate the overall impact and cost-effectiveness of varicella immunization programs. Knowledge about the cause and incidence of varicella-related hospitalizations in Turkey is limited, center-specific and not sufficiently accurate. The aim of this multicenter study (VARICOMP) was to estimate the annual incidence of pediatric varicella-related hospitalization, describe the associated complications and estimate the annual mortality and economic cost of these cases.

NCT ID: NCT01866566 Recruiting - Varicella Clinical Trials

The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination

Start date: June 2013
Phase: Phase 4
Study type: Interventional

Through evaluating the immunogenicity and safety for Varicella vaccine two doses immune procedure we could supply scientific and practical evidence for this two doses immune procedure promotion and management.

NCT ID: NCT01830283 Enrolling by invitation - Varicella Clinical Trials

The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination

Start date: April 2013
Phase: Phase 4
Study type: Interventional

To investigate the safety, immunogenicity and immune effect of the Varicella vaccine after the 2nd dose vaccination in Chao yang district, Bei jing, since the 2nd varicella vaccination was promoted by Beijing Center for Disease Control and Prevention in November, 2012.

NCT ID: NCT01817270 Completed - Chickenpox Clinical Trials

Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine

Start date: March 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the occurrence of adverse events, seroconversion rate and geometric mean titres(GMTs) of 2 doses of live attenuated varicella vaccine.

NCT ID: NCT01815073 Completed - Clinical trials for Japanese Encephalitis

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Start date: March 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the occurrence of adverse events and seroconversion rate, geometric mean titres (GMTs) of live attenuated varicella vaccine,live attenuated JE vaccine and live attenuated varicella vaccine combined with live attenuated JE vaccine, respectively.

NCT ID: NCT01738841 Withdrawn - Measles Clinical Trials

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Start date: August 2013
Phase: N/A
Study type: Observational

This study will collect data on the safety of the MMRV vaccine (Priorix-Tetra™) used in routine practice in children aged 12 months to 12 years living in the Philippines.

NCT ID: NCT01684072 Completed - Chickenpox Clinical Trials

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin

Start date: January 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the occurrence of adverse reaction and antibody positive rate, the elevated level of antibody,Geometric mean titer (GMT) between groups of live attenuated varicella vaccine without gelatin.

NCT ID: NCT01626794 Withdrawn - Varicella Clinical Trials

A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)

Start date: July 2014
Phase: Phase 3
Study type: Interventional

This study will test the immunogenicity, safety, and tolerability of VARIVAX™ manufactured with the Varicella Enhanced Process (VEP) compared with the VARIVAX™ 2007 Process. The primary hypotheses being tested are 1)VARIVAX™ VEP will induce varicella-zoster virus (VZV) antibody responses that are non-inferior to those induced by VARIVAX™ 2007 process at 6 weeks after vaccination 1, and 2) VARIVAX™ VEP will induce an acceptable anti-VZV antibody response rate at 6 weeks after vaccination 1.

NCT ID: NCT01536405 Completed - Measles Clinical Trials

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Start date: June 5, 2012
Phase: Phase 3
Study type: Interventional

This study will compare the safety, tolerability, and immunogenicity of measles, mumps, rubella, and varicella (MMRV) vaccine made with an alternative manufacturing process with those of the 2006 process